News

A recent study revealed that heart function is an important risk factor in the development of dementia and Alzheimer’s disease. The study entitled “Low Cardiac Index is Associated with Incident Dementia and Alzheimer’s Disease: The Framingham Heart Study” was published in Circulation by…

According to a recent study conducted by a researcher from the University of Eastern Finland, the cognitive functioning of patients with Alzheimer’s disease and their behavioral and psychological difficulties are associated with their daily living activities. However, the researchers found that deficits in cognitive performance were not associated…

According to a recent study from researchers at the Keck School of Medicine of the University of Southern California, reduced expression of a protein called GLUT1, responsible for moving glucose in the brain-blood barrier (BBB) worsens Alzheimer’s disease cerebrovascular degeneration, neuropathology and cognitive function, suggesting that GLUT1 may represent…

The Alzheimer’s Drug Discovery Foundation (ADDF) is proud to announce that it is the Official Charity Partner of the 2015 TCS New York City Marathon. The Foundation is inviting runners that were not able to secure individual spots in the 2015 TCS New York City Marathon to be part of the Runners for Alzheimer’s…

The documentary “Looks Like Laury, Sounds Like Laury,” which tells the story of a woman fighting Frontotemporal Dementia, will premiere on American television next Tuesday, March 10th at 8 pm on the World Channel. The film produced by Pamela Hogan and Connie Shulman will be broadcasted as part of the third…

Researchers at Northwestern University have recently reported in the journal Brain that the amyloid plaques characteristic of Alzheimer’s disease can be found in young adult brains. The study is entitled “Neuronal amyloid-β accumulation within cholinergic basal forebrain in aging and Alzheimer’s disease.” Alzheimer’s disease…

The Irish subsidiary of biopharmaceutical company Transition Therapeutics Inc. has finished patient enrollment for its phase 2 clinical study to assess a novel therapy for mild, moderate and severe Alzheimer’s disease. Transition Therapeutics Ireland Limited (TTIL) will now evaluate the neuropsychiatric drug candidate ELND005, expecting it…

According to medical specialists, research published last year stating that Vitamin B does not prevent Alzheimer’s disease is misleading, causing patients in early stages of the disease to miss out a potentially valuable treatment. Expert researchers and clinicians strongly criticized the previous study, saying that it is “inaccurate and misleading,” and are…

A team of Mexican scientists have developed a skin test that may provide an enhanced perspective on Alzheimer’s and Parkinson’s diseases, according to a study scheduled for presentation at The 67th American Academy of Neurology (AAN) Annual Meeting to be held April 18-25, 2015, at the Walter…

A collaboration between scientists from Dublin’s Trinity College (Ireland) and the University of Queensland (Australia) identified a compound able to inhibit an inflammatory process common to many diseases, including Alzheimer’s disease. The study entitled “A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases”…